CRRTF
Price
$0.34
Change
-$0.02 (-5.56%)
Updated
Sep 9 closing price
Capitalization
6.45M
LIFD
Price
$0.29
Change
+$0.01 (+3.57%)
Updated
Sep 24 closing price
Capitalization
4.3M
Interact to see
Advertisement

CRRTF vs LIFD

Header iconCRRTF vs LIFD Comparison
Open Charts CRRTF vs LIFDBanner chart's image
Crescita Therapeutics
Price$0.34
Change-$0.02 (-5.56%)
Volume$615
Capitalization6.45M
LFTD Partners
Price$0.29
Change+$0.01 (+3.57%)
Volume$100
Capitalization4.3M
CRRTF vs LIFD Comparison Chart in %
Loading...
CRRTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIFD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRRTF vs. LIFD commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRRTF is a Hold and LIFD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 01, 2025
Stock price -- (CRRTF: $0.34 vs. LIFD: $0.29)
Brand notoriety: CRRTF and LIFD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRRTF: 52% vs. LIFD: 6%
Market capitalization -- CRRTF: $6.45M vs. LIFD: $4.3M
CRRTF [@Pharmaceuticals: Generic] is valued at $6.45M. LIFD’s [@Pharmaceuticals: Generic] market capitalization is $4.3M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRRTF’s FA Score shows that 0 FA rating(s) are green whileLIFD’s FA Score has 1 green FA rating(s).

  • CRRTF’s FA Score: 0 green, 5 red.
  • LIFD’s FA Score: 1 green, 4 red.
According to our system of comparison, LIFD is a better buy in the long-term than CRRTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRRTF’s TA Score shows that 3 TA indicator(s) are bullish while LIFD’s TA Score has 4 bullish TA indicator(s).

  • CRRTF’s TA Score: 3 bullish, 3 bearish.
  • LIFD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LIFD is a better buy in the short-term than CRRTF.

Price Growth

CRRTF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LIFD (@Pharmaceuticals: Generic) price change was +3.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.69%. For the same industry, the average monthly price growth was +45.06%, and the average quarterly price growth was +96.58%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.69% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRRTF($6.45M) has a higher market cap than LIFD($4.3M). CRRTF YTD gains are higher at: -24.120 vs. LIFD (-40.816). CRRTF has higher annual earnings (EBITDA): 91K vs. LIFD (-11.91K). CRRTF has more cash in the bank: 8.18M vs. LIFD (2.12M). CRRTF has less debt than LIFD: CRRTF (602K) vs LIFD (4.38M). LIFD has higher revenues than CRRTF: LIFD (36.6M) vs CRRTF (20.3M).
CRRTFLIFDCRRTF / LIFD
Capitalization6.45M4.3M150%
EBITDA91K-11.91K-764%
Gain YTD-24.120-40.81659%
P/E RatioN/A13.93-
Revenue20.3M36.6M55%
Total Cash8.18M2.12M387%
Total Debt602K4.38M14%
FUNDAMENTALS RATINGS
CRRTF vs LIFD: Fundamental Ratings
CRRTF
LIFD
OUTLOOK RATING
1..100
3012
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
3463
P/E GROWTH RATING
1..100
8532
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIFD's Valuation (53) in the null industry is in the same range as CRRTF (56). This means that LIFD’s stock grew similarly to CRRTF’s over the last 12 months.

LIFD's Profit vs Risk Rating (100) in the null industry is in the same range as CRRTF (100). This means that LIFD’s stock grew similarly to CRRTF’s over the last 12 months.

LIFD's SMR Rating (92) in the null industry is in the same range as CRRTF (94). This means that LIFD’s stock grew similarly to CRRTF’s over the last 12 months.

CRRTF's Price Growth Rating (34) in the null industry is in the same range as LIFD (63). This means that CRRTF’s stock grew similarly to LIFD’s over the last 12 months.

LIFD's P/E Growth Rating (32) in the null industry is somewhat better than the same rating for CRRTF (85). This means that LIFD’s stock grew somewhat faster than CRRTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRRTFLIFD
RSI
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
31%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
40%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRRTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIFD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCPL2.380.14
+6.25%
NETCAPITAL INC.
TBBB26.790.53
+2.02%
BBB Foods
CMS72.770.93
+1.29%
CMS Energy Corp
MGTX8.250.07
+0.86%
MeiraGTx Holdings plc
RBKB11.44-0.40
-3.38%
Rhinebeck Bancorp

CRRTF and

Correlation & Price change

A.I.dvisor tells us that CRRTF and LIFD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRRTF and LIFD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRRTF
1D Price
Change %
CRRTF100%
N/A
LIFD - CRRTF
29%
Poorly correlated
N/A
SIGA - CRRTF
26%
Poorly correlated
-2.18%
CWBHF - CRRTF
4%
Poorly correlated
+72.28%
CTTH - CRRTF
2%
Poorly correlated
+19.12%
ECGS - CRRTF
2%
Poorly correlated
-7.04%
More

LIFD and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIFD has been loosely correlated with LVZPF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIFD jumps, then LVZPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIFD
1D Price
Change %
LIFD100%
N/A
LVZPF - LIFD
34%
Loosely correlated
N/A
CRRTF - LIFD
29%
Poorly correlated
N/A
BFRI - LIFD
6%
Poorly correlated
+0.83%
HLN - LIFD
5%
Poorly correlated
+0.23%
SHPH - LIFD
3%
Poorly correlated
-5.24%
More